ArticleArthritis research & therapy2026
DAS28-ESR may underestimate disease activity in rheumatoid arthritis patients with nonalcoholic fatty liver disease: a retrospective cohort study.
Article in Arthritis research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough approximately one-third of patients with rheumatoid arthritis (RA) have comorbid nonalcoholic fatty liver disease (NAFLD), the clinical characteristics of these patients remain unclear. The aim of this study was to clarify the clinical characteristics of RA patients classified as having NAFLD based on imaging, with a focus on composite disease activity assessment.
methodsThis retrospective cohort study analysed data from 349 RA patients enrolled in the Nagahama Riumachi Cohort between March 2017 and August 2023. Patients with liver diseases other than NAFLD were excluded. NAFLD was classified based on findings from abdominal computed tomography and/or ultrasonography performed during the cohort period. Disease activity was assessed using the Clinical Disease Activity Index (CDAI), Simplified Disease Activity Index (SDAI), Disease Activity Score in 28 joints using C-reactive protein (DAS28-CRP), and Disease Activity Score in 28 joints using erythrocyte sedimentation rate (DAS28-ESR). Functional status was evaluated using the Health Assessment Questionnaire Disability Index (HAQ-DI). Factors associated with NAFLD were examined by logistic regression, and repeated measurements during follow-up were analysed using linear mixed-effects models.
resultsSeventy-three patients (20.9%) were classified as having NAFLD and 276 (79.1%) as not having NAFLD. Patients in the NAFLD group were younger, had a higher proportion of men, and had a higher prevalence of body mass index (BMI) ≥ 25 kg/m². There were no significant differences between the groups in disease activity assessed by CDAI, SDAI, or DAS28-CRP. However, the NAFLD group had significantly lower DAS28-ESR and erythrocyte sedimentation rate (ESR) values despite similar C-reactive protein (CRP) levels. HAQ-DI was lower in the NAFLD group, especially in the lower-limb domain. In multivariable analysis, younger age and higher (BMI) were independently associated with NAFLD, but ESR and HAQ-DI were not significantly associated. In linear mixed-effects models, NAFLD classification was not significantly associated with ESR, although ESR tended to be lower in the NAFLD group.
conclusionsAmong patients with RA classified as having NAFLD, DAS28-ESR may underestimate disease activity compared with CRP-based or clinical indices. In these patients, DAS28-CRP, CDAI, and SDAI may provide complementary information.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.